Azacitidine-containing induction regimens followed by azacitidine maintenance therapy in high risk acute myeloid leukemia: First results of the randomized phase-II AMLSG 12-09 study (clinicaltrials.gov No. NCT01180322)

This article has no abstract
Epistemonikos ID: bac22c317ec41305c3c7d21fb4ceb5ce3bde176d
First added on: Feb 05, 2025